Violich Capital Management Inc. Invests $217,000 in MAXIMUS, Inc. (MMS)

Violich Capital Management Inc. Invests $217,000 in MAXIMUS, Inc. (MMS)

Other large investors have also recently bought and sold shares of the company. Russell Investments Group Ltd. purchased a new stake in MAXIMUS during the fourth quarter valued at $19,752,000. Two Sigma Investments LP bought a new stake in shares of MAXIMUS during the fourth quarter worth approximately $258,000. Janus Capital Management LLC raised its stake in shares of MAXIMUS by 5.5% in the fourth quarter. Janus Capital Management LLC now owns 2,406,771 shares of the health services provider’s stock worth $134,274,000 after buying an additional 126,514 shares during the last quarter. Citadel Advisors LLC bought a new stake in shares of MAXIMUS during the third quarter worth approximately $546,000. Finally, Keybank National Association OH raised its stake in shares of MAXIMUS by 515.3% in the fourth quarter. Keybank National Association OH now owns 24,113 shares of the health services provider’s stock worth $1,345,000 after buying an additional 20,194 shares during the last quarter. Institutional investors own 98.74% of the company’s stock.

Violich Capital Management Inc. bought a new stake in MAXIMUS, Inc. (NYSE:MMS) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 3,490 shares of the health services provider’s stock, valued at approximately $217,000.

Shares of MAXIMUS, Inc. (NYSE:MMS) traded down 0.83% during midday trading on Tuesday, hitting $61.88. 302,112 shares of the company were exchanged. The firm has a market capitalization of $4.01 billion, a price-to-earnings ratio of 20.29 and a beta of 1.13. The firm’s 50 day moving average price is $61.28 and its 200 day moving average price is $58.35. MAXIMUS, Inc. has a one year low of $43.69 and a one year high of $64.25.

MAXIMUS (NYSE:MMS) last released its earnings results on Thursday, May 4th. The health services provider reported $0.80 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.78 by $0.02. MAXIMUS had a net margin of 8.08% and a return on equity of 26.42%. The company had revenue of $622 million for the quarter, compared to the consensus estimate of $620.24 million. During the same quarter in the previous year, the company earned $0.74 EPS. MAXIMUS’s quarterly revenue was up 2.6% compared to the same quarter last year. Analysts forecast that MAXIMUS, Inc. will post $3.05 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 31st. Shareholders of record on Monday, May 15th will be issued a dividend of $0.045 per share. The ex-dividend date is Thursday, May 11th. This represents a $0.18 annualized dividend and a yield of 0.29%. MAXIMUS’s payout ratio is 5.98%.

A number of equities research analysts recently commented on the stock. KeyCorp restated a “sector weight” rating on shares of MAXIMUS in a report on Thursday, May 25th. ValuEngine lowered shares of MAXIMUS from a “buy” rating to a “hold” rating in a report on Tuesday, May 16th. Jefferies Group LLC lowered shares of MAXIMUS from a “buy” rating to a “hold” rating and raised their price objective for the stock from $63.00 to $64.00 in a report on Friday, May 5th. Maxim Group lowered shares of MAXIMUS from a “buy” rating to a “hold” rating and set a $66.00 price objective on the stock. in a report on Thursday, May 4th. They noted that the move was a valuation call. Finally, Canaccord Genuity restated a “buy” rating and set a $62.00 price objective on shares of MAXIMUS in a report on Friday, April 7th. One analyst has rated the stock with a sell rating, six have issued a hold rating and one has assigned a buy rating to the company. MAXIMUS currently has a consensus rating of “Hold” and an average target price of $61.33.

In other MAXIMUS news, President Bruce Caswell sold 17,197 shares of the company’s stock in a transaction on Thursday, May 11th. The shares were sold at an average price of $62.47, for a total transaction of $1,074,296.59. Following the transaction, the president now owns 27,904 shares in the company, valued at $1,743,162.88. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Richard A. Montoni sold 30,000 shares of the company’s stock in a transaction on Thursday, March 9th. The stock was sold at an average price of $60.59, for a total transaction of $1,817,700.00. Following the transaction, the chief executive officer now owns 614,114 shares in the company, valued at approximately $37,209,167.26. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 126,407 shares of company stock worth $7,839,076. Corporate insiders own 3.10% of the company’s stock.

About MAXIMUS

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “MMS”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MAXIMUS, Inc. (NYSE:MMS).

Related posts

Leave a Comment